TrademarkDir
THE WORLD'S FIRST UNIVERSAL GENE THERAPY
DEAD

Serial Number

97527017

Owner

Siren Biotechnology, Inc.

Filing Date

Jul 29, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

THE WORLD'S FIRST UNIVERSAL GENE THERAPY Trademark

Serial Number: 97527017

THE WORLD'S FIRST UNIVERSAL GENE THERAPY is a trademark filed by Siren Biotechnology, Inc. on July 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Siren Biotechnology, Inc. (17 trademarks)

953 Indiana Street
San Francisco, CA 94107

Entity Type: 03

Trademark Details

Filing Date

July 29, 2022

Registration Date

Not Registered

Goods & Services

Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 24, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 24, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 8, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2024 CRFA
ASSIGNED TO LIE
Jan 25, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2023 TROA
NOTICE OF REVIVAL - E-MAILED
Sep 6, 2023 NREV
NOTICE OF REVIVAL - E-MAILED
Sep 6, 2023 NREV
PETITION TO REVIVE-GRANTED
Sep 6, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Sep 6, 2023 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 5, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sep 5, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 5, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 19, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 19, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 19, 2023 CNRT
ASSIGNED TO EXAMINER
May 15, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 20, 2022 NWOS
NEW APPLICATION ENTERED
Aug 2, 2022 NWAP

Related Trademarks

More from this Owner

S logo

S

SIREN

SIREN

SIREN

SIREN

SIREN BIOTECHNOLOGY logo

SIREN BIOTECHNOLOGY

CURING CANCER UNIVERSALLY

CURING CANCER UNIVERSALLY

CURING CANCER UNIVERSALLY

CURING CANCER UNIVERSALLY